Cargando…
Integrated Decision-Making in the Treatment of Colon-Rectal Cancer: The Case of KRAS-Mutated Tumors
In recent years, precision medicine has taken an increasing place in various branches of medical oncology, including colorectal cancer. Among the potentially relevant mutations for this cancer is the KRAS mutation, initially defined as “untargetable”; today, we see the birth of new molecules that ta...
Autores principales: | Cherri, Sara, Melocchi, Laura, Gandolfi, Laura, Rossi, Giulio, Zaniboni, Alberto |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9967356/ https://www.ncbi.nlm.nih.gov/pubmed/36836752 http://dx.doi.org/10.3390/life13020395 |
Ejemplares similares
-
Microsatellite instability and chemosensitivity in solid tumours
por: Cherri, Sara, et al.
Publicado: (2022) -
Optimizing the first-line treatment for metastatic colorectal cancer
por: Cherri, Sara, et al.
Publicado: (2023) -
Is the oncologic patient more susceptible to covid19 but perhaps less likely to undergo severe infection-related complications due to fewer cytokines storm as a consequent of the associated immunodeficiency?
por: Cherri, Sara, et al.
Publicado: (2020) -
Pancreatic adenocarcinoma: Beyond first line, where are we?
por: Cherri, Sara, et al.
Publicado: (2021) -
New drugs for the treatment of metastatic colorectal cancer
por: Cherri, Sara, et al.
Publicado: (2021)